Wednesday, June 30, 2021 9:34:17 AM
Some additional info on Dr Dionne and his confidence in Mipsagargin and his ability to transform cancer treatment.
This new drug treatment acts like a grenade because its toxic chemical is released from its wrapping only when it makes contact with a specific molecule in the blood vessels feeding tumors. Results from Phase II of this new drug treatment are showing promising results, GenSpera (www.genspera.com) is planning phase three testing for 2016, which could put mipsagargin on track for FDA approval for widespread use in 2018. "Cancer can't escape OUR drug. There is no way to get around it," Dionne says.
Dr. Craig Dionne is well on his way to be becoming the Steve Jobs of the bio tech world. In Alan Dukes new interview with Dr. Dionne he compares his accomplishments in cancer research, passion for finding a cure, and his creative innovative approach on par with other technological innovators –including Elon Musk, Jeff Bezos and Larry Page.
Many have listened to Dr Dionne only to be still waiting on mipsagargin.
Recent RBSH News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:19:43 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:36:33 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM